Caxton Associates LP Adma Biologics, Inc. Transaction History
Caxton Associates LP
- $2.65 Billion
- Q3 2024
A detailed history of Caxton Associates LP transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Caxton Associates LP holds 75,848 shares of ADMA stock, worth $1.22 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
75,848
Previous 206,727
63.31%
Holding current value
$1.22 Million
Previous $2.31 Million
34.4%
% of portfolio
0.06%
Previous 0.08%
Shares
7 transactions
Others Institutions Holding ADMA
# of Institutions
312Shares Held
184MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$300 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$291 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$209 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$203 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$138 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.16B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...